Title: A new synthetic approach to 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-benzimidazol-2-one(J-113397), the first non-peptide ORL-1 receptor antagonist.
Journal: Bioorganic & medicinal chemistry 20010701
1209904-16-4
10029-09-1
100959-19-1
1015846-36-2
102450-00-0
124-09-4
59455-06-0 | spiro[imidazolidine-4,8'-tricyclo[5.2.1.0,2,6]decane]-2,5-dione | AA01BHN1 | MFCD17237707
1566883-08-6 | 1-(2,3-dihydrobenzofuran-2-yl)pent-4-en-1-one | AA01BHT1 | MFCD24270785
1261862-87-6 | 3-FLUORO-2-HYDROXYPHENYLACETIC ACID | AA01BI0E | MFCD18396864
288151-53-1 | 4,8-dichloro-2,7-dimethylquinoline | AA01BIAP | MFCD28128377
1152495-27-6 | 1,2-dimethyl 4-(chlorosulfonyl)benzene-1,2-dicarboxylate | AA01BIEU | MFCD11102997
1261762-28-0 | 2-Chloro-4-(trifluoromethoxy)benzenesulfonamide | AA01BITT | MFCD18393780
1016503-75-5 | N-(2-methoxyphenyl)piperidine-3-carboxamide | AA01BIYU | MFCD09805975
344294-91-3 | methyl 6-chloro-5-oxoheptanoate | AA01BJ6M | MFCD20625754
1339432-40-4 | 2,8-dichloro-3-methylquinoline | AA01BJF0 | MFCD18299055
1567020-33-0 | 3-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-PYRIDINE-2-CARBOXYLIC ACID | AA01BK1M | MFCD03427725